Navigation Links
Cerulean Pharma to Present Data on CRLX101's HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
Date:4/4/2013

CAMBRIDGE, Mass., April 4, 2013 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that researchers will present both pre-clinical and clinical data on Cerulean's Phase 2 candidate, CRLX101, in sessions at the American Association for Cancer Research (AACR) Annual Meeting. Among the findings, Cerulean will share clinical data from a study evaluating synergy between CRLX101 and Avastin® (bevacizumab).

(Logo:  http://photos.prnewswire.com/prnh/20130107/NE37515LOGO )

In multiple animal models, CRLX101 inhibits hypoxia-inducible factor 1a (HIF-1a), which is involved in cancer survival mechanisms, and which is up-regulated in the hypoxic conditions created by anti-angiogenic drugs. Animal models suggest that CRLX101 is synergistic with multiple anti-angiogenic drugs, and this hypothesis is being tested in a clinical trial combining CRLX101 with Avastin, the leading anti-angiogenic medicine.

Dr. Stephen M. Keefe , the Ann B. Young Assistant Professor in Cancer Research at the Perelman School of Medicine at the University of Pennsylvania, will present a poster entitled A Phase Ib-2a Study Evaluating the Nanopharmaceutical CRLX101 in Combination with Bevacizumab (April 9, 8:00 am – 12:00 pm) on a clinical trial studying synergy between CRLX101 and Avastin when combined to treat patients with advanced renal cell carcinoma. Dr. Keefe, who practices at the Abramson Cancer Center of the University of Pennsylvania, will present data showing that the CRLX101-Avastin combination has been well tolerated in six patients treated to date with no dose limiting toxicities observed. Additional patients are being enrolled in the study to confirm combinability and to assess efficacy.

"The pre-clinical data for CRL
'/>"/>

SOURCE Cerulean Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
2. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. Valeant Pharmaceuticals Provides Update to Recent Event
5. X-BODY Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co., Ltd., A Leading Pharmaceutical Company In China, To Develop Novel Therapeutic Antibodies For AMD
6. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
7. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
8. DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs
9. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
10. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
11. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
(Date:8/27/2014)... , Aug. 27, 2014  CVS Caremark (NYSE: ... into a new clinical affiliation with MedStar Health, a ... Maryland and the Washington, ... high-quality, affordable health care services for patients. Through this ... access to clinical support, medication counseling, chronic disease monitoring ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3
... 2010 Curemark LLC , a drug research and ... today that it has been awarded a grant by the ... Program to advance the development of its lead product CM-AT ... at 18 sites around the US. The QTDP ...
... VALLEY, Calif., Nov. 2, 2010 Spectros Corporation ... with the T-Stat VLS Tissue Oximeter at the ... newly released data was presented during poster sessions ... Circulation: Pharmacology/Physiology", held at the American Society of ...
Cached Medicine Technology:Curemark Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant 2Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010 2
(Date:8/27/2014)... August 27, 2014 Taking its popular obstacle ... Steele Creek YMCA will host its largest crowd at ... Saturday, September 13 at YMCA Camp Thunderbird . ... divisions: adult, youth and teams. Within each division, runners ... their physical limit - for a worthy cause. All ...
(Date:8/27/2014)... 27, 2014 Reviewing the prices that ... be easier for the public when using the Quotes ... promoted in all 50 states in the U.S. are ... different insurers that are generating the rates information from ... adults to use the programmed system without charge. Because ...
(Date:8/27/2014)... Shawna's new book, released in ebook ... Digging, which a brand-new technique she created. Seed digging ... to bring permanent healing quickly. , According to Burns, ... disorders cured on a daily basis. It teaches people ... find incredible inner peace with only a few simple ...
(Date:8/27/2014)... The New York Mobility Club (sponsored ... events about “ Sexuality & Intimacy ” for people ... and entertaining discussions are for mature audiences only. September ... Avenue, Mamaroneck, NY) and October 7 from 6-8 pm ... , The New York Mobility Club is a local ...
(Date:8/27/2014)... 2014 Top 10 Best SEO Hosting, a ... hosting suppliers and announced iPage, Bluehost and GoDaddy are the ... Australia and Europe to buy useful hosting (including VPS and ... suppliers, iPage has been serving hosting small business ... has grown into a leader in the hosting industry for ...
Breaking Medicine News(10 mins):Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Shawna Burns, Counselor, Releases Debut Book, "Seed Digging," to Improve Lives of Children and Adults with Addictions and Mental Health Disorders 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2
... BIRMINGHAM, Ala., Sept. 8 BioCryst Pharmaceuticals, Inc. (Nasdaq: ... summaries at two upcoming investor conferences. , , ... is scheduled to present a corporate summary at the Rodman & ... 2:25 p.m. Eastern Time. The conference will be held September 9-11, ...
... ... Use in Epocrates Survey , ... San Mateo, CA (PRWEB) September 8, 2009 -- Epocrates, Inc., a leading provider ... role of technology use in hospitals and clinics across the nation. , , ,The majority ...
... , , , ... on its recent analysis of the dairy animal nutrition market, ... business of Church & Dwight Company Incorporated, with the 2009 ... the Year Award. It acknowledges the company,s excellence in developing ...
... , , LONDON, Sept. ... Ingredients Excellence in Financial & Risk Management Award is presented ... the first and only EU-and FDA-approved omega-3 derived prescription drug. ... the USA, the product is a prescribed adjunct to diet ...
... ... in using electronic cigarette, the private research group has recently completed survey of 10,000 ... ... is a battery-powered device that provides inhaled doses of nicotine by delivering a vaporized ...
... ... testimonial for ColorAlchemy by licensed Marriage and Family Therapist and Clinical Hypnotherapist David Swindoll now ... ... Therapist and Clinical Hypnotherapist for over thirty years. He has found the use of ColorAlchemy ...
Cached Medicine News:Health News:BioCryst Executives to Present at Two Investor Conferences 2Health News:Nurses Facing National Shortage Turn to Mobile Technology to Support Patient Care 2Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 2Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 3Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 2Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 3Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 5Health News:Electronic Cigarette Known as ecig Helps You Quit Smoking 2Health News:Electronic Cigarette Known as ecig Helps You Quit Smoking 3Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 2Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 3
... for urinary albumin that allows for early ... CLIA Waived test has a sensitivity of ... gives accurate results in only 3 minutes ... hours. Since early detection is one key ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
Medicine Products: